Breast cancer prevention for BRCA1 and BRCA2 mutation carriers: is there a role for tamoxifen?-Reference-Cited by-同舟云学术

Breast cancer prevention for BRCA1 and BRCA2 mutation carriers: is there a role for tamoxifen?

Published:2014-03 Issue:4 Volume:10 Page:499-502
ISSN:1479-6694
Container-title:Future Oncology
language:en
Short-container-title:Future Oncology

Author:

Phillips Kelly-Anne¹²³⁴,Lindeman Geoffrey J⁵⁶⁷

Affiliation:

1. Division of Cancer Medicine, Peter MacCallum Cancer Centre, Locked Bag 1, A’Beckett St, Victoria, 8006, Australia

2. Sir Peter MacCallum Department of Oncology, The University of Melbourne, Australia

3. Centre for Molecular, Environmental, Genetic & Analytic Epidemiology, School of Population & Global Health, The University of Melbourne, Australia

4. Department of Medicine, St Vincent’s Hospital, The University of Melbourne, Australia

5. ACRF Stem Cells & Cancer Division, The Walter & Eliza Hall Institute of Medical Research, Australia

6. Familial Cancer Centre, Royal Melbourne Hospital, Australia

7. Department of Medicine, Royal Melbourne Hospital, The University of Melbourne, Australia

Publisher

Future Medicine Ltd

Subject

Cancer Research,Oncology,General Medicine

Link

https://www.futuremedicine.com/doi/pdf/10.2217/fon.13.278

Reference27 articles.

1. Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies

2. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: breast cancer risk reduction version 1 (2013). www.nccn.org/professionals/physician_gls/f_guidelines.asp#breast_risk

3. Preventing breast and ovarian cancers in high‐risk BRCA1 and BRCA2 mutation carriers

4. Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data

5. Tamoxifen and Breast Cancer Incidence Among Women With Inherited Mutations in BRCA1 and BRCA2

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Cancer Prevention Strategies in Individuals With Hereditary Cancer Syndromes: Focus on BRCA1, BRCA2, and Lynch Syndrome;American Society of Clinical Oncology Educational Book;2024-06

2. Update on Adipose Tissue and Cancer;Endocrine Reviews;2023-06-01

3. Nonsurgical Options for Risk Reduction of Contralateral Breast Cancer in BRCA Mutation Carriers With Early-Stage Breast Cancer;Journal of Clinical Oncology;2023-02-10

4. Treatment Patterns, Safety, and Patient Reported Outcomes among Adult Women with Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer with or without, or with Unknown, <b><i>BRCA1/2</i></b> Mutation(s): Results of a Real-World Study from the United States, United Kingdom, and four EU Countries;Breast Care;2022

5. Nonsurgical Prevention Strategies in BRCA1 and BRCA2 Mutation Carriers;Breast Care;2020-05-11